These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17767193)

  • 1. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation.
    Puccetti P; Grohmann U
    Nat Rev Immunol; 2007 Oct; 7(10):817-23. PubMed ID: 17767193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
    Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
    Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species.
    Ogasawara N; Oguro T; Sakabe T; Matsushima M; Takikawa O; Isobe K; Nagase F
    J Cell Biochem; 2009 Oct; 108(3):716-25. PubMed ID: 19693771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.
    Grohmann U; Volpi C; Fallarino F; Bozza S; Bianchi R; Vacca C; Orabona C; Belladonna ML; Ayroldi E; Nocentini G; Boon L; Bistoni F; Fioretti MC; Romani L; Riccardi C; Puccetti P
    Nat Med; 2007 May; 13(5):579-86. PubMed ID: 17417651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
    Puccetti P; Fallarino F
    Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape.
    Wang H; Pan K; Xia JC
    Ai Zheng; 2009 Feb; 28(2):184-7. PubMed ID: 19550135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
    Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
    Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
    Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan catabolism generates autoimmune-preventive regulatory T cells.
    Fallarino F; Grohmann U; You S; McGrath BC; Cavener DR; Vacca C; Orabona C; Bianchi R; Belladonna ML; Volpi C; Fioretti MC; Puccetti P
    Transpl Immunol; 2006 Dec; 17(1):58-60. PubMed ID: 17157218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma.
    Maneechotesuwan K; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Yaikwawong M; Barnes PJ; Wongkajornsilp A
    J Allergy Clin Immunol; 2009 Jan; 123(1):239-48. PubMed ID: 19058839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic dendritic cells in health and disease: friend and foe!
    Adler HS; Steinbrink K
    Eur J Dermatol; 2007; 17(6):476-91. PubMed ID: 17951127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoregulatory role of IDO-producing human dendritic cells revisited.
    Terness P; Chuang JJ; Opelz G
    Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
    Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
    Witkiewicz A; Williams TK; Cozzitorto J; Durkan B; Showalter SL; Yeo CJ; Brody JR
    J Am Coll Surg; 2008 May; 206(5):849-54; discussion 854-6. PubMed ID: 18471709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
    Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
    Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.
    Manches O; Fernandez MV; Plumas J; Chaperot L; Bhardwaj N
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14122-7. PubMed ID: 22879398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.